Catalyst Pharmaceuticals, Inc. (CPRX) Stock Historical ... 102 rows · Discover historical prices for CPRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Catalyst Pharmaceuticals, Inc. stock was issued. Catalyst Pharmaceuticals, Inc. (CPRX) Stock Price, Quote ... Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. CPRX Stock Price | Catalyst Pharmaceuticals Inc. Stock ... CPRX | Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Should you invest in Catalyst Pharmaceuticals (NasdaqCM:CPRX)? Exceptional growth management. Stable Share Price: CPRX's share price has been volatile over the past 3 months. Historical annual earnings growth CPRX, NasdaqCM (Nasdaq Capital Market), Yes, Common Stock, US, USD, Nov 2006. CN2, DB
Catalyst Pharmaceuticals, Inc. (CPRX) latest earnings report: revenue, EPS, surprise, history, news and analysis. Catalyst Pharmaceuticals, Inc. - CPRX - Stock Price Today ... View Catalyst Pharmaceuticals, Inc. CPRX investment & stock information. Get the latest Catalyst Pharmaceuticals, Inc. CPRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. CPRX | Catalyst Pharmaceuticals Inc. Stock Price & News - WSJ Catalyst Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CPRX stock price.
Catalyst Pharmaceuticals (CPRX) has 0 splits in our CPRX split history database.. Looking at the CPRX split history from start to finish, an original position size …
Catalyst Pharmaceuticals, Inc. Common Stock (CPRX ...
Dividend (TTM) is a widely used stock evaluation measure. Find the latest Dividend (TTM) for Catalyst Pharmaceuticals, Inc. (CPRX)
CPRX Split History Catalyst Pharmaceuticals (CPRX) has 0 splits in our CPRX split history database.. Looking at the CPRX split history from start to finish, an original position size … Catalyst Pharmaceuticals, Inc. (CPRX) stock price, quote ... Catalyst Pharmaceuticals, Inc. (Catalyst) (CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that it will release fourth quarter and year end 2019 financial results after market Catalyst Pharmaceuticals, Inc. (CPRX) Quant Ratings ... An overall objective rating for Catalyst Pharmaceuticals, Inc. (CPRX) optimized for predictive value. Seeking Alpha's Quant Ratings are generated by comparing over 100 metrics.
Real-time trade and investing ideas on Catalyst Pharmaceutical Partners Inc. CPRX from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk,
Get today's Catalyst Pharmaceuticals Inc stock price and latest CPRX news as well as Catalyst Pharmaceuticals real-time stock quotes, technical analysis, full View today's stock price, news and analysis for Catalyst Pharmaceuticals Inc. ( CPRX). Barron's also provides information on historical stock ratings, target prices, Catalyst Pharmaceuticals, Inc Stock Chart and Share Price Forecast, Short-Term "CPRX" Stock Prediction Current, Vs Industry, Vs History. 3-Year Average Share Buyback Ratio, -8.5. Valuation & Return. Current, Vs Industry, Vs History. Price-to-Tangible-Book, 4.59 . CPRX Catalyst Pharmaceuticals, Inc. daily Stock Chart Business Drive Catalyst Pharmaceuticals's (NASDAQ:CPRX) Lovely 416% Share Price Gain? Simply
Mar 31, 2020 · Find the latest Earnings Report Date for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com. CPRX Stock Price and Chart — NASDAQ:CPRX — TradingView With a confluence of strong fundamentals and technical setup CPRX should see $8.60 as a first medium term price target, a 50% price increase from closing price on 10/25/19. Long term CPRX has the potential to go materially higher than first price target based on fundamentals and sell-side consensus. CPRX -- Is Its Stock Price A Worthy Investment? Learn More. CPRX Stock Summary. The ratio of debt to operating expenses for Catalyst Pharmaceuticals Inc is higher than it is for about just 7.62% of US stocks. In terms of twelve month growth in earnings before interest and taxes, Catalyst Pharmaceuticals Inc is reporting a growth rate of -198.25%; that's higher than merely 7.42% of US stocks.